Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ITGA5 mRNA | affects expression | 21346803
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein results in increased expression of and affects the localization of [ITGA5 protein binds to ITGB3 protein]] | affects binding|affects localization|decreases reaction|increases expression | 16465378
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ITGA5 mRNA | affects expression | 21346803
|
C426703 |
3-(3-(3-(4,5-dihydroimidazol-2-ylamino)propyloxylisoxazol-5-yl)carbonylamino)-2-(phenylsulfonylamino)propionic acid |
3-(3-(3-(4,5-dihydroimidazol-2-ylamino)propyloxylisoxazol-5-yl)carbonylamino)-2-(phenylsulfonylamino)propionic acid binds to and results in decreased activity of [ITGA5 protein binds to ITGB3 protein] | affects binding|decreases activity | 16384862
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of ITGA5 mRNA | decreases expression | 12419474
|
D000096 |
Acetone |
Acetone results in increased expression of ITGA5 mRNA | increases expression | 12720008
|
D000537 |
Aluminum Oxide |
[Aluminum Oxide co-treated with Magnesium] results in increased expression of ITGA5 protein | affects cotreatment|increases expression | 12209937
|
C047981 |
arginyl-glycyl-aspartic acid |
arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol binds to [ITGA5 protein binds to ITGB3 protein]] | affects binding|decreases reaction | 16790523
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of ITGA5 mRNA | decreases expression | 12419474
|
C422910 |
Cilengitide |
Cilengitide results in decreased activity of [ITGA5 protein binds to ITGB3 protein] | affects binding|decreases activity | 16729916
|
C422910 |
Cilengitide |
Cilengitide results in decreased activity of [ITGA5 protein binds to ITGB5 protein] | affects binding|decreases activity | 16729916
|
C018021 |
cobaltous chloride |
cobaltous chloride results in increased expression of ITGA5 protein | increases expression | 16798617
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in increased expression of ITGA5 mRNA | increases expression | 15829613
|
C529593 |
EMD 527040 |
EMD 527040 binds to and results in decreased activity of [ITGA5 protein binds to ITGB6 protein] | affects binding|decreases activity | 18221819
|
D000431 |
Ethanol |
Ethanol results in increased expression of ITGA5 mRNA | increases expression | 12720008
|
D005492 |
Folic Acid |
Folic Acid affects the expression of ITGA5 mRNA | affects expression | 16361273
|
D005665 |
Furosemide |
Furosemide results in decreased expression of ITGA5 mRNA | decreases expression | 16526316
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of ITGA5 mRNA | decreases expression | 12419474
|
D016729 |
Leuprolide |
Leuprolide inhibits the reaction [IGF1 protein results in increased expression of and affects the localization of [ITGA5 protein binds to ITGB3 protein]] | affects binding|affects localization|decreases reaction|increases expression | 17143537
|
D008274 |
Magnesium |
[Aluminum Oxide co-treated with Magnesium] results in increased expression of ITGA5 protein | affects cotreatment|increases expression | 12209937
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of ITGA5 mRNA | increases expression | 15674843
|
C007350 |
nitrofen |
nitrofen results in increased expression of ITGA5 protein | increases expression | 15119844
|
D011374 |
Progesterone |
Progesterone affects the expression of ITGA5 mRNA | affects expression | 17962213
|
D011374 |
Progesterone |
Progesterone affects the expression of ITGA5 protein | affects expression | 17962213
|
C037219 |
quinoline |
quinoline analog binds to and results in decreased activity of [ITGA5 protein binds to ITGB3 protein] | affects binding|decreases activity | 16984141
|
C059514 |
resveratrol |
arginyl-glycyl-aspartic acid inhibits the reaction [resveratrol binds to [ITGA5 protein binds to ITGB3 protein]] | affects binding|decreases reaction | 16790523
|
C059514 |
resveratrol |
[ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK1 protein] | affects binding|increases phosphorylation|increases reaction | 16790523
|
C059514 |
resveratrol |
[ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of MAPK3 protein] | affects binding|increases phosphorylation|increases reaction | 16790523
|
C059514 |
resveratrol |
[ITGA5 protein binds to ITGB3 protein] promotes the reaction [resveratrol results in increased phosphorylation of TP53 protein] | affects binding|increases phosphorylation|increases reaction | 16790523
|
C059514 |
resveratrol |
resveratrol binds to [ITGA5 protein binds to ITGB3 protein] | affects binding | 16790523
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of ITGA5 mRNA | increases expression | 18175754
|
D014284 |
Triiodothyronine |
Triiodothyronine binds to [ITGA5 protein binds to ITGB3 protein] | affects binding | 16384862
|
D013974 |
Thyroxine |
Thyroxine binds to [ITGA5 protein binds to ITGB3 protein] | affects binding | 16384862
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ITGA5 mRNA | increases expression | 16051281
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of ITGA5 mRNA | affects binding|decreases expression | 16214954
|
C011126 |
tetraiodothyroacetic acid |
tetraiodothyroacetic acid binds to [ITGA5 protein binds to ITGB3 protein] | affects binding | 16384862
|
D019772 |
Topotecan |
ITGA5 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.54 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.54 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ethanol |
4.22 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
8.19 | 16316344 16595132 17003819 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
8.19 | 16538975 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
10.65 | 16963246 |
MESH:D000236 |
Adenoma |
|
Magnesium |
10.65 | 17823441 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.65 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.03 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
4.38 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.38 | 16183991 16162502 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.93 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.71 | 11748828 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.55 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.79 | 11141031 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.33 | 17115116 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.63 | 10378619 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.11 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.73 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
Leuprolide |
2.73 | 17187010 |
MESH:D001321 |
Autistic Disorder |
|
Magnesium |
2.73 | 16846101 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.88 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.80 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.59 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.05 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.98 | 15665606 15845082 15380490 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.00 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
1.97 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.97 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
1.97 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.88 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.69 | 17687719 10378619 |
MESH:D002056 |
Burns |
|
Ethanol |
4.38 | 16374292 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.58 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.39 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.39 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
8.39 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
quinoline |
8.39 | 598648 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.39 | 16227395 19321006 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.31 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.64 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
10.67 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
10.67 | 18850075 18670907 16120746 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
10.67 | 18093424 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
11.24 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
11.24 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
11.24 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.58 | 6135515 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.48 | 15894690 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
7.40 | 15513904 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
7.40 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
9.27 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
9.27 | 8946559 21254359 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.27 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.86 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.41 | 16338953 |
MESH:D003111 |
Colonic Polyps |
|
Magnesium |
5.79 | 17823441 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
3.65 | 17245555 16985020 17087956 17116713 16963246 |
MESH:D015179 |
Colorectal Neoplasms |
|
Magnesium |
3.65 | 17823441 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.65 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.57 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
3.81 | 19302082 15513904 15451039 10194807 15451040 11198716 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
3.81 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.81 | 10048152 15322242 20055451 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
5.18 | 16037377 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.98 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.98 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
3.77 | 15059100 11298694 16823706 |
MESH:D002658 |
Developmental Disabilities |
|
Magnesium |
4.72 | 16846101 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.54 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.55 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
4.32 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.32 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.73 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.22 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.08 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.08 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
11.08 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
11.08 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.08 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.56 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.66 | 16935035 |
MESH:D004487 |
Edema |
|
Furosemide |
14.48 | 11834646 |
MESH:D004487 |
Edema |
|
Mustard Gas |
14.48 | 9260866 11428631 11402378 11428647 |
MESH:D004487 |
Edema |
|
resveratrol |
14.48 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.48 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.62 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.46 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.46 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
3.83 | 17301261 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.13 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.13 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.57 | 17923197 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.88 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.68 | 16704527 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
5.21 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
3.49 | 16409862 19236843 18620774 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.38 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.02 | 16946407 10194807 15451040 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.68 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
10.70 | 15046732 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
10.70 | 17171786 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.82 | 16504073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.59 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
10.57 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
10.57 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.57 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
3.89 | 12660669 16845234 16011733 |
MESH:D006390 |
Hemangioendothelioma |
|
quinoline |
5.62 | 598648 |
MESH:D006394 |
Hemangiosarcoma |
|
quinoline |
4.75 | 598648 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.09 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.62 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
3.84 | 16292651 15578192 7576705 12759764 9473106 11584395 18958481 11076806 10541330 17245593 16473863 15088113 10359170 12904592 16863852 15793718 18280291 9859898 11588001 15756563 17270546 16720372 9575882 12021965 11685700 18280292 12746050 12407540 12547725 10898224 9476886 8863223 10370017 16490937 10646786 7520565 15707848 12194112 16080930 10370016 10898222 12505043 11051153 11057544 15764645 15136996 17618886 7760232 10693666 11409163 9698600 15185205 11329586 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.90 | 16876885 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
5.21 | 17209195 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.50 | 18783367 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
4.82 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.37 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.76 | 17188708 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
4.26 | 16395265 16865747 16397167 16433478 16755160 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.77 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.59 | 15086907 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.80 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.01 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.06 | 17488730 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.37 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.59 | 16096441 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.36 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.13 | 15811171 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.57 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.57 | 17600658 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
10.79 | 11402378 8975870 11428647 17524151 9357497 11428620 11428631 9260866 16001271 |
MESH:D007249 |
Inflammation |
|
Progesterone |
10.79 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
10.79 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.79 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.26 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.10 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.29 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.29 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
3.62 | 11041285 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.02 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
6.62 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
6.62 | 16705839 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.94 | 15451040 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
3.66 | 12970779 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.40 | 16087638 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.62 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
EMD 527040 |
7.29 | 18221819 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
7.29 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.82 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
arginyl-glycyl-aspartic acid |
3.66 | 15547672 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
3.66 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.66 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
2.98 | 16877991 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.38 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
6.81 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
6.81 | 19073162 19812893 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.81 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.16 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.16 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
7.38 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
7.38 | 17245593 16863852 9614859 9859898 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
2.32 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 19555203 11884234 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
3.26 | 17718048 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
9.42 | 17088997 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
9.42 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.65 | 14749477 |
MESH:D008275 |
Magnesium Deficiency |
|
Magnesium |
6.17 | 17823441 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.97 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.67 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
5.67 | 11606380 8985016 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.41 | 16832597 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.33 | 17992120 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.92 | 18411066 15451040 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.13 | 17112576 |
MESH:D008881 |
Migraine Disorders |
|
Magnesium |
4.57 | 18803445 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.27 | 16267019 17049120 17935668 16490592 14749477 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.59 | 17962980 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.91 | 17188708 17125593 16525036 17015251 16456233 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.28 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.28 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.48 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.41 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.41 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Leuprolide |
5.76 | 17143537 |
MESH:D009362 |
Neoplasm Metastasis |
|
quinoline |
3.93 | 598648 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.73 | 8985016 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.59 | 15086907 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.95 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
3.78 | 17438019 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.71 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.58 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.14 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
8.74 | 16322990 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
8.74 | 7688884 16761898 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.59 | 17945291 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.08 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.08 | 16049721 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.00 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
4.99 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.99 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.87 | 12384795 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.82 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.96 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.22 | 11550810 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.54 | 15727166 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.37 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.66 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.66 | 11118676 11222880 11896295 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cilengitide |
2.39 | 16729916 |
MESH:D011471 |
Prostatic Neoplasms |
|
Leuprolide |
2.39 | 17143537 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.39 | 17675339 15767336 17804756 17718901 17636462 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.39 | 18760546 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.81 | 18058305 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.82 | 17720292 17894541 10334151 17266442 17620002 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
4.51 | 15728788 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.30 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
marker/mechanism |
|
| 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
6.67 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.67 | 16314181 16317513 17058453 15827377 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
4.36 | 12394941 15912074 16096441 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.76 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
2.86 | 16641680 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.78 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
8.78 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
8.78 | 9754883 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
5.07 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
5.07 | 16961503 12880345 15451306 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
12.51 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
12.51 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
12.51 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.51 | 16192470 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
5.21 | 16361298 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.00 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 17786296 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
3.54 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
3.54 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
3.54 | 17052386 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.29 | 11906479 9562338 16755016 17189318 17918041 9211565 |
MESH:D020521 |
Stroke |
|
Folic Acid |
4.11 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.24 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.01 | 9754883 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.43 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
11.43 | 19910387 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.97 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
4.64 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
4.64 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.05 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.05 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
3.86 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.87 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.03 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |